| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 2.02B | 1.03B | 700.29M | 517.69M |
| Gross Profit | 585.01M | 282.20M | 202.19M | 151.43M |
| EBITDA | 252.53M | 151.65M | 114.59M | 73.45M |
| Net Income | 135.43M | 93.53M | 66.63M | 33.19M |
Balance Sheet | ||||
| Total Assets | 1.73B | 1.32B | 762.82M | 542.42M |
| Cash, Cash Equivalents and Short-Term Investments | 161.52M | 60.46M | 32.20M | 212.70M |
| Total Debt | 127.72M | 65.27M | 95.18M | 106.93M |
| Total Liabilities | 310.71M | 100.81M | 114.98M | 120.98M |
| Stockholders Equity | 1.35B | 1.22B | 647.84M | 421.44M |
Cash Flow | ||||
| Free Cash Flow | 332.25M | -406.39M | -317.86M | 38.10M |
| Operating Cash Flow | 463.84M | -308.07M | -291.10M | 44.62M |
| Investing Cash Flow | -286.27M | -99.07M | -24.22M | -7.61M |
| Financing Cash Flow | -92.97M | 435.40M | 134.83M | 162.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | ₹9.19B | 62.20 | ― | 0.06% | 97.10% | 40.93% | |
57 Neutral | ₹1.44B | 13.41 | ― | ― | 16.20% | 267.95% | |
57 Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% | |
54 Neutral | ₹3.83B | 26.23 | ― | ― | 22.45% | 26.18% | |
45 Neutral | ₹3.29B | 32.06 | ― | 0.46% | -22.06% | -79.52% | |
44 Neutral | ₹112.72M | -24.88 | ― | ― | ― | ― | |
37 Underperform | ₹360.69M | -7.79 | ― | ― | 1.19% | 0.32% |
Krishival Foods Limited has announced that its Rights Issue Committee approved the allotment of 33,33,160 partly paid-up equity shares with a face value of ₹10 each on a rights basis to eligible shareholders and renouncees at its meeting on 8 January 2026. In line with SEBI’s capital-raising and disclosure regulations, the company has published the basis of allotment for these shares in leading English, Hindi and Marathi newspapers and made the information available on its website, underscoring its adherence to regulatory norms and its efforts to keep investors informed as it augments its equity capital base.
Krishival Foods Limited has completed the allotment phase of its recently concluded rights issue, which opened on December 26, 2025 and closed on January 7, 2026. Following the finalisation of the basis of allotment in consultation with its registrar and approval from the National Stock Exchange of India as the designated stock exchange, the Rights Issue Committee approved the allotment of 3,333,160 partly paid-up equity shares of face value ₹10 each to eligible shareholders and renouncees at an application amount of ₹105 per share, including share premium. As a result, the company’s paid-up equity share capital now includes these partly paid shares, reflecting ₹1,16,66,060 received as application money, with the remaining amount to be collected through one or more future calls by January 6, 2027. The move increases Krishival’s equity base and signals continued use of equity financing to support its growth or operational needs, with future calls on the partly paid shares providing additional, phased capital inflows for the company and its stakeholders.
The stock exchange has asked Krishival Foods Limited to provide clarification for its financial results for the quarter ended 30 September 2025 in relation to Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements. The company’s response is still pending, leaving investors and other stakeholders awaiting further details on the nature of the query and any potential implications for its reported quarterly performance and regulatory compliance.
Krishival Foods Limited has announced a rights issue of partly paid equity shares to raise up to ₹10,000 lakhs. The rights issue is set at a price of ₹300 per share, with a record date of December 17, 2025, and will be open from December 26, 2025, to January 5, 2026. This move aims to strengthen the company’s capital base and potentially enhance its market positioning by allowing existing shareholders to increase their stake.
Krishival Foods Limited announced the postponement of its Board meeting initially scheduled for December 2, 2025, due to pending in-principle approvals from stock exchanges for a Rights Issue. This delay impacts the company’s planned issuance of partly paid-up equity shares, which is a strategic move to raise up to Rs. 10,000 Lakhs. The rescheduling reflects the company’s commitment to ensuring compliance with regulatory requirements and maintaining transparency with stakeholders.